CSL has an Environment, Health, Safety and Sustainability (EHS2) Strategic Plan which ensures its facilities operate to industry and regulatory standards. This strategy includes compliance with government regulations and commitments to continuously improve the health and safety of the workforce as well as minimising the impact of operations on the environment. To drive this strategy, an internal Global CSL EHS2 Management System (EHS2MS) Standard has been developed and gives regard to the international standards, ISO 14001 Environmental Management Systems and draft ISO 45001 Occupational Health and Safety Management Systems.
Aside from minor sewer permit non-compliances detailed below; no environmental breaches have been notified by the Environment Protection Authority (EPA) in Victoria, Australia or by any other equivalent Australian interstate or foreign government agency in relation to CSL’s Australian, European, North American or Asia Pacific operations during the year ended 30 June 2018. During the year CSL has directly engaged with EPA Victoria regarding historical contamination of groundwater in a small portion of the Parkville, Australia, site and has been in discussion with the EPA on actions to remediate any impact. This engagement is ongoing.
In addition, a letter of non-compliance with trade waste agreement requirements was issued to CSL by the local water authority in relation to an elevated sample result for sulphide in wastewater discharged to the sewer from the Parkville site. CSL is working with the authority to resolve this issue to their satisfaction. A second non-compliance with a wastewater permit limit sampling issue at the Holly Springs (USA) site has been rectified with the authority and subsequent sampling is demonstrating compliance.
For 2017/18, increasing production output is reflected in an increasing environmental footprint, however environmental initiatives, together with increasing use of the production capacity of recently built plants, led to decreasing energy, greenhouse gas (GHG) and water intensities. Nonetheless, CSL’s facilities require significant amounts of energy and water for operational procedures such as test runs, validation of equipment and operation when not at full capacity. Furthermore, HVAC energy consumption for clean room areas is nearly independent of production output. CSL continues to be challenged by its expanding manufacturing footprint, which is growing to help meet product demand and deliver new and improved therapies to patients.
Our Environmental Impact Trends
In 2015/16, CSL increased its footprint from five to seven manufacturing sites following the acquisition of the Novartis influenza vaccine business. For comparative purposes, we have provided data from 2014 to 2015 which excludes the Novartis influenza vaccine acquired sites.